Loading...
•
Dec 31, 2022
Utah Medical Q4 2022 Earnings Report
Utah Medical Products experienced a solid Q4 performance, leading to financial results for 2022 exceeding initial projections.
Key Takeaways
Utah Medical Products reported a 5.1% increase in Q4 2022 revenues compared to Q4 2021, with net income rising by 10.3%. The company's EPS also increased by 11.2%. While domestic sales saw a decrease, OUS sales increased significantly, although these were impacted by stronger USD.
Total consolidated sales increased by 5.1% compared to Q4 2021.
Net income increased by 10.3% compared to Q4 2021.
Diluted EPS increased by 11.2% compared to Q4 2021.
OUS sales increased by 25%, but were affected by a stronger USD.
Revenue by Geographic Location
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...